Article metrics

Download PDFPDF

A recombinant HER2/neu expressing listeria monocytogenes (Lm-LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma - a Phase I clinical trial
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2024

AbstractFullPdf
Dec 2019020
Jan 2020031
Feb 2020031
Mar 2020010
Apr 2020001
May 2020020
Jun 2020050
Jul 2020030
Aug 2020020
Sep 2020050
Nov 2020020
Dec 2020011
Jan 2021031
Feb 2021011
Mar 2021020
Apr 2021040
May 2021010
Jul 2021010
Aug 2021030
Sep 2021061
Oct 2021032
Nov 2021075
Dec 2021051
Jan 2022042
Feb 2022030
Mar 2022021
Apr 2022061
May 2022060
Jun 2022021
Jul 2022041
Aug 2022062
Sep 2022030
Oct 2022051
Nov 20220140
Dec 2022091
Jan 2023031
Feb 2023030
Mar 2023010
Apr 2023011
May 2023021
Jun 2023031
Jul 2023011
Aug 2023020
Sep 2023020
Oct 2023021
Nov 2023061
Dec 2023061
Jan 2024040
Feb 2024091
Mar 2024072
Apr 20240134
May 2024071
Total020141